Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients

被引:0
|
作者
Jan J. De Waele
J. Lipman
M. Akova
M. Bassetti
G. Dimopoulos
M. Kaukonen
D. Koulenti
C. Martin
P. Montravers
J. Rello
A. Rhodes
A. A. Udy
T. Starr
S. C. Wallis
J. A. Roberts
机构
[1] Ghent University Hospital,Department of Critical Care Medicine
[2] The University of Queensland,Burns Trauma and Critical Care Research Centre
[3] Royal Brisbane and Women’s Hospital,Attikon University Hospital
[4] Hacettepe University Hospital,Department of Epidemiology and Preventive Medicine, Monash University
[5] Azienda Ospedaliera Universitaria Santa Maria della Misericordia,CIBERES
[6] University of Athens Medical School,Department of Intensive Care and Hyperbaric Medicine
[7] Helsinki University Hospital,undefined
[8] Australian and New Zealand Intensive Care Research Centre (ANZIC RC),undefined
[9] Hospital Nord,undefined
[10] Centre Hospitalier Universitaire Bichat-Claude Bernard,undefined
[11] Vall d’Hebron Institut of Research,undefined
[12] St George’s Healthcare NHS Trust and St George’s University of London,undefined
[13] The Alfred Hospital,undefined
来源
Intensive Care Medicine | 2014年 / 40卷
关键词
β-Lactam antibiotics; Pharmacokinetics; Pharmacodynamics; Critical care;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1340 / 1351
页数:11
相关论文
共 50 条
  • [1] Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients
    De Waele, Jan J.
    Lipman, J.
    Akova, M.
    Bassetti, M.
    Dimopoulos, G.
    Kaukonen, M.
    Koulenti, D.
    Martin, C.
    Montravers, P.
    Rello, J.
    Rhodes, A.
    Udy, A. A.
    Starr, T.
    Wallis, S. C.
    Roberts, J. A.
    INTENSIVE CARE MEDICINE, 2014, 40 (09) : 1340 - 1351
  • [2] Erratum to: Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients
    Jan J. De Waele
    J. Lipman
    M. Akova
    M. Bassetti
    G. Dimopoulos
    M. Kaukonen
    D. Koulenti
    C. Martin
    P. Montravers
    J. Rello
    A. Rhodes
    A. A. Udy
    T. Starr
    S. C. Wallis
    J. A. Roberts
    Intensive Care Medicine, 2015, 41 : 969 - 969
  • [3] Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients (vol 40, pg 1340, 2014)
    De Waele, Jan J.
    Lipman, J.
    Akova, M.
    Bassetti, M.
    Dimopoulos, G.
    Kaukonen, M.
    Koulenti, D.
    Martin, C.
    Montravers, P.
    Rello, J.
    Rhodes, A.
    Udy, A. A.
    Starr, T.
    Wallis, S. C.
    Roberts, J. A.
    INTENSIVE CARE MEDICINE, 2015, 41 (05) : 969 - 969
  • [4] An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy
    Sahand Imani
    Hergen Buscher
    Richard Day
    Sheridan Gentili
    Graham R. D. Jones
    Debbie Marriott
    Ross Norris
    Indy Sandaradura
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 2171 - 2175
  • [5] An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric -lactam therapy
    Imani, Sahand
    Buscher, Hergen
    Day, Richard
    Gentili, Sheridan
    Jones, Graham R. D.
    Marriott, Debbie
    Norris, Ross
    Sandaradura, Indy
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (11) : 2171 - 2175
  • [6] Correction to: An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy
    Sahand Imani
    Hergen Buscher
    Richard Day
    Sheridan Gentili
    Graham R. D. Jones
    Debbie Marriott
    Ross Norris
    Indy Sandaradura
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 1789 - 1789
  • [7] An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy (vol 37, pg 2171, 2018)
    Imani, Sahand
    Buscher, Hergen
    Day, Richard
    Gentili, Sheridan
    Jones, Graham R. D.
    Marriott, Debbie
    Norris, Ross
    Sandaradura, Indy
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (08) : 1789 - 1789
  • [8] Predictors for non-attainment of meropenem target concentrations when treating infections in critically ill patients
    Zheng, Shaojun
    Xu, Yifan
    Chen, Naidong
    Hao, Jingwen
    Zhu, Yubing
    Jie, Qiong
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2024, 62 (01) : 1 - 7
  • [9] Evaluation of the MeroRisk Calculator, A User-Friendly Tool to Predict the Risk of Meropenem Target Non-Attainment in Critically Ill Patients
    Liebchen, Uwe
    Klose, Marian
    Paal, Michael
    Vogeser, Michael
    Zoller, Michael
    Schroeder, Ines
    Schmitt, Lisa
    Huisinga, Wilhelm
    Michelet, Robin
    Zander, Johannes
    Scharf, Christina
    Weinelt, Ferdinand A.
    Kloft, Charlotte
    ANTIBIOTICS-BASEL, 2021, 10 (04):
  • [10] Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT)
    Alan Abdulla
    Annemieke Dijkstra
    Nicole G. M. Hunfeld
    Henrik Endeman
    Soma Bahmany
    Tim M. J. Ewoldt
    Anouk E. Muller
    Teun van Gelder
    Diederik Gommers
    Birgit C. P. Koch
    Critical Care, 24